DNA SEQUENCING MARKET ANALYSIS

DNA Sequencing Market, by Product Type (Consumables, Instruments, and Services), by Technology (Sanger Sequencing, Next-Generation Sequencing, Third- Generation DNA Sequencing, and Others), by Application (Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, Metagenomics, Epidemiology & Drug Development, and Others), by End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Clinical Research, and Others), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Mar 2025
Code : CMI5531
Pages :208
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global DNA Sequencing Market: Key Developments

On January 9, 2023, Illumina Inc., a pharmaceutical company, and Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), announced an agreement with Amgen, a biopharmaceutical company, for whole-genome sequence of DNA samples approximately 35,000 samples. This agreement helped in accelerating therapeutic development through genomics and establish a preeminent clinico-genomic data set.